A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women
Background: Allostatic load (AL), a measure of physiologic dysregulation across multiple systems, has been shown to increase as women age and go through menopause. While hormone use has been shown to help with the relief of menopausal symptoms, it is not clear whether the use of hormone replacement...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Aging and Health Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667032124000349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850106441074999296 |
|---|---|
| author | Pamela Lamisi Alebna Joaquin Ignacio Armendano Nasim Maleki |
| author_facet | Pamela Lamisi Alebna Joaquin Ignacio Armendano Nasim Maleki |
| author_sort | Pamela Lamisi Alebna |
| collection | DOAJ |
| description | Background: Allostatic load (AL), a measure of physiologic dysregulation across multiple systems, has been shown to increase as women age and go through menopause. While hormone use has been shown to help with the relief of menopausal symptoms, it is not clear whether the use of hormone replacement therapy and hormonal contraceptives in the perimenopausal period has an impact on alleviating allostatic load in aging women. Methods: We conducted a target trial emulation to estimate the on-treatment (i.e., per-protocol) effect of hormone replacement therapy or hormonal contraceptives use on AL score evolution over time. We included in our analysis 2,199 women from the SWAN cohort that were followed-up between 1996 and 2005. To estimate the effect of the continuous use of hormone replacement therapy or hormonal contraceptives on AL score evolution over the follow-up period we used marginal structural models estimated using inverse probability weighting. Results: The mean AL score at baseline was 2.45 ± 1.85 (Mean ± SD). The AL score remained relatively stable in women that never used hormone replacement therapy or hormonal contraceptives, with an average increase of 0.014 ± 0.011 (Mean ± SE) per year, whereas in women that used hormone replacement therapy or hormonal contraceptives continuously, the AL score increased, on average 0.087 ± 0.014 (Mean ± SE) per year. We did not find conclusive evidence to support that continuous use of hormone replacement therapy or hormonal contraceptives modifies the AL score trajectory (mean difference between trends = 0.073; CI95%: -0.027, 0.173; P = 0.1538). Conclusion: Continuous use of hormone replacement therapy or hormonal contraceptives during the menopause transition period was not associated with increased allostatic load. The findings suggest continuous use of hormone therapy as a treatment for perimenopausal symptoms in aging women doesn't confer a risk for increased allostatic load. |
| format | Article |
| id | doaj-art-e814a0689bc64183afa5a3b62e9c5607 |
| institution | OA Journals |
| issn | 2667-0321 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Aging and Health Research |
| spelling | doaj-art-e814a0689bc64183afa5a3b62e9c56072025-08-20T02:38:49ZengElsevierAging and Health Research2667-03212025-03-015110021310.1016/j.ahr.2024.100213A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal womenPamela Lamisi Alebna0Joaquin Ignacio Armendano1Nasim Maleki2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Internal Medicine, Rutgers/Robert Wood Johnson Barnabas Health, Jersey City Medical Center, USANational University of the Center of the Province of Buenos Aires, Tandil, BA, ArgentinaDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Corresponding authorat: Massachusetts General Hospital, Suite 101E, Building 120, Second Avenue, Charlestown, MA, 02129, USA.Background: Allostatic load (AL), a measure of physiologic dysregulation across multiple systems, has been shown to increase as women age and go through menopause. While hormone use has been shown to help with the relief of menopausal symptoms, it is not clear whether the use of hormone replacement therapy and hormonal contraceptives in the perimenopausal period has an impact on alleviating allostatic load in aging women. Methods: We conducted a target trial emulation to estimate the on-treatment (i.e., per-protocol) effect of hormone replacement therapy or hormonal contraceptives use on AL score evolution over time. We included in our analysis 2,199 women from the SWAN cohort that were followed-up between 1996 and 2005. To estimate the effect of the continuous use of hormone replacement therapy or hormonal contraceptives on AL score evolution over the follow-up period we used marginal structural models estimated using inverse probability weighting. Results: The mean AL score at baseline was 2.45 ± 1.85 (Mean ± SD). The AL score remained relatively stable in women that never used hormone replacement therapy or hormonal contraceptives, with an average increase of 0.014 ± 0.011 (Mean ± SE) per year, whereas in women that used hormone replacement therapy or hormonal contraceptives continuously, the AL score increased, on average 0.087 ± 0.014 (Mean ± SE) per year. We did not find conclusive evidence to support that continuous use of hormone replacement therapy or hormonal contraceptives modifies the AL score trajectory (mean difference between trends = 0.073; CI95%: -0.027, 0.173; P = 0.1538). Conclusion: Continuous use of hormone replacement therapy or hormonal contraceptives during the menopause transition period was not associated with increased allostatic load. The findings suggest continuous use of hormone therapy as a treatment for perimenopausal symptoms in aging women doesn't confer a risk for increased allostatic load.http://www.sciencedirect.com/science/article/pii/S2667032124000349AgingAllostatic loadMenopauseHormone therapy |
| spellingShingle | Pamela Lamisi Alebna Joaquin Ignacio Armendano Nasim Maleki A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women Aging and Health Research Aging Allostatic load Menopause Hormone therapy |
| title | A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women |
| title_full | A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women |
| title_fullStr | A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women |
| title_full_unstemmed | A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women |
| title_short | A longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women |
| title_sort | longitudinal analysis on the effect of hormone use on allostatic load in perimenopausal women |
| topic | Aging Allostatic load Menopause Hormone therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2667032124000349 |
| work_keys_str_mv | AT pamelalamisialebna alongitudinalanalysisontheeffectofhormoneuseonallostaticloadinperimenopausalwomen AT joaquinignacioarmendano alongitudinalanalysisontheeffectofhormoneuseonallostaticloadinperimenopausalwomen AT nasimmaleki alongitudinalanalysisontheeffectofhormoneuseonallostaticloadinperimenopausalwomen AT pamelalamisialebna longitudinalanalysisontheeffectofhormoneuseonallostaticloadinperimenopausalwomen AT joaquinignacioarmendano longitudinalanalysisontheeffectofhormoneuseonallostaticloadinperimenopausalwomen AT nasimmaleki longitudinalanalysisontheeffectofhormoneuseonallostaticloadinperimenopausalwomen |